Overview
Robert Douglas is a Radiation Oncologist in Seattle, Washington. Dr. Douglas is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Posterior Fossa Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer. Dr. Douglas is currently accepting new patients.
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1221 Madison St, Suite 1, Seattle, WA 98104
The Association Of University Physicians
Jay Liao is a Radiation Oncologist in Seattle, Washington. Dr. Liao is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Salivary Gland Tumors, Prostate Cancer, Muscle Invasive Bladder Cancer, Familial Prostate Cancer, and Gastrostomy. Dr. Liao is currently accepting new patients.
Virginia Mason Medical Center
Andrew Suen is a Radiation Oncologist in Seattle, Washington. Dr. Suen is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Anal Cancer, and Pleuropulmonary Blastoma. Dr. Suen is currently accepting new patients.
The Association Of University Physicians
Annemarie Shepherd is a Radiation Oncologist in Seattle, Washington. Dr. Shepherd is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Lung Cancer, Thymic Epithelial Tumor, Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma. Dr. Shepherd is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Posterior Fossa TumorDr. Douglas isDistinguished. Learn about Posterior Fossa Tumor.
- Advanced
- Anal CancerDr. Douglas isAdvanced. Learn about Anal Cancer.
- AngiosarcomaDr. Douglas isAdvanced. Learn about Angiosarcoma.
- AstrocytomaDr. Douglas isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Breast CancerDr. Douglas isAdvanced. Learn about Breast Cancer.
- Embryonal Tumor with Multilayered Rosettes
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Douglas isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acoustic NeuromaDr. Douglas isExperienced. Learn about Acoustic Neuroma.
- Adenoid Cystic CarcinomaDr. Douglas isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Douglas isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Douglas isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Bone TumorDr. Douglas isExperienced. Learn about Bone Tumor.